Systemic mast cell disease (mastocytosis). General aspects and histopathological diagnosis

Histology and Histopathology

Volumn 12, Issue 4, 1997, Pages 1081-1089

  Horny, H P ^a,b   Ruck, P ^a   Krober S ^a   Kaiserling, E ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Malignant mastocytosis; Mast cell; Mastocytosis; Systemic mast cell disease; Tryptase

Indexed keywords

MONOCLONAL ANTIBODY;

CELL DIFFERENTIATION; CYTODIAGNOSIS; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAST CELL; MASTOCYTOSIS; REVIEW; SPLEEN;

ANIMALS; HUMANS; IMMUNOHISTOCHEMISTRY; MASTOCYTOSIS;

EID: 0030814553     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Agis H., Füreder W., Bankl H.C., Kundi M., Sperr W.R., Willheim M., Boltz-Nitulescu G., Butterfield J.H., Kishi K., Lechner K. and Valent P. (1996). Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes. Immunology 87, 535-543.
2. Brunning R.D., McKenna R.W., Rosai J., Parkin J.L. and Risdall R. (1983). Systemic mastocytosis, extracutaneous manifestations. Am. J. Surg. Pathol. 7, 425-438.
3. Ellis J.M. (1949). Urticaria pigmentosa: a report of a case with autopsy. Arch. Pathol. 48, 426-435.
4. Horny H.-P. and Kaiserling E. (1988). Lymphoid cells and tissue mast cells of bone marrow lesions in systemic mastocytosis: a histological and immunohistological study. Br. J. Haematol. 69, 449-455.
5. Horny H.-P., Parwaresch M.R. and Lennert K. (1983). Klinisches Bild und Prognose generalisierter Mastozytosen. Klin. Wochenschr. 61, 192-197.
6. Horny H.-P., Parwaresch M.R. and Lennert K. (1985). Bone marrow findings in systemic mastocytosis. Hum. Pathol. 16, 808-814.
7. Horny H.-P., Parwaresch M.R., Kaiserling E., Müller K., Olbermann M., Mainzer K. and Lennert K. (1986). Mast cell sarcoma of the larynx. J. Clin. Pathol. 39, 596-602.
8. Horny H.-P., Reimann O. and Kaiserling E. (1987). Immunoreactivity of normal and neoplastic human tissue mast cells. Am. J. Clin. Pathol. 89, 335-340.
9. Travis W.D., Li C.-Y., Hoagland H.C., Travis L.B. and Banks P.M. (1986). Mast cell leukemia: report of a case and review of the literature. Mayo Clin. Proc. 61, 957-966.
10. Travis W.D., Li C.-Y., Bergstralh E.J., Yam L.T. and Swee R.G. (1988a). Systemic mast cell disease. Analysis of 58 cases and literature review. Medicine 67, 345-368.
11. Travis W.D., Li C.-Y., Yam L.T., Bergstralh M.S. and Swee R.G. (1988b). Significance of systemic mast cell disease with associated hematologic disorders. Cancer 62, 965-972.
12. Valent P. (1995). Mast cell differentiation antigens: expression in normal and malignant cells and use for diagnostic purposes. Eur. J. Clin. Invest. 25, 715-720.
13. Webb T.A., Li C.-Y. and Yam L.T. (1982). Systemic mast cell disease: a clinical and hematopathologic study of 26 cases. Cancer 49, 927-938.
14. Zhang Y., Schlegelberger B., Weber-Matthiesen K., Grote W. and Bartels H. (1994). Translocation (X;8) (q2?6;q21.3) in a case of systemic mastocytosis. Cancer Genet. Cytogenet. 78, 236-238.